SEPSIMATIC
LIVE

Serial Number

79423158

Owner

Bruker Daltonics GmbH & Co. KG

Attorney

Paul Novak

Filing Date

Mar 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SEPSIMATIC Trademark

Serial Number: 79423158

SEPSIMATIC is a trademark filed by Bruker Daltonics GmbH & Co. KG on March 25, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently pending registration.

Owner Contact Info

Bruker Daltonics GmbH & Co. KG

Fahrenheitstraße 4

Entity Type: 28

Trademark Details

Filing Date

March 25, 2025

Registration Date

Not Registered

Goods & Services

Laboratory apparatus and instruments other than for medical use, namely, automated sample processing stations, robotic arms, and fluid handling systems for scientific analysis; Laboratory apparatus and instruments, namely apparatus and equipment for taking, processing and/or preparation of biological samples from a vessel for analytical purposes, in particular a fully or partially automated blood culture sampling and processing station for taking blood culture samples from blood culture bottles and processing and preparing the samples for further mass spectrometric analysis with the purpose of identification of microorganism in the samples and/or a sepsis; Embedded computer programs and computer software for controlling laboratory instruments other than for medical use, namely, automated sample processing stations, robotic arms, and fluid handling systems for scientific analysis; Embedded computer programs and computer software for controlling an apparatus for taking, preparation and processing of samples from a vessel for scientific purposes, in particular blood culture samples, for the analysis by mass spectrometry and for analyzing mass spectra data, and/or for identifying microorganisms including bacteria, yeasts and fungi, and particles including virions in a liquid culture from biological, industrial and food samples

Reagents for scientific purposes; Media for cell culture for use in non-medical research laboratories; Buffer solutions for scientific purposes, in particular lysis buffer media and washing buffer media; Media for microbiological culture or cell culture for use in separation techniques, not for medical use, in particular extraction media; Reagents for analytical purposes, not for medical or veterinary purposes, in particular matrix substance media; Chemical-biological test kits for detecting sepsis for scientific purposes comprising buffer solutions, reagents, media and matrix substance media; Reagents for scientific purposes, media for microbiological culture or cell culture for use in separation techniques for use in non-medical research laboratories, buffer solutions for scientific purposes, in particular lysis buffer media and washing buffer media, media for use in separation techniques, not for medical use, in particular extraction media, reagents for analytical purposes, other than for medical or veterinary purposes, in particular matrix substance media, and chemical- biological test kits comprising buffer solutions, reagents, media and matrix substance media, all for detecting sepsis for research use for non-medical, nonclinical and non-veterinary diagnostics; Reagents for scientific purposes, media for microbiological culture or cell culture for use in separation techniques for cell culture for use in non-medical research laboratories, buffer solutions for scientific purposes, in particular lysis buffer media and washing buffer media, media for use in separation techniques, not for medical use, in particular extraction media, reagents for analytical purposes, other than for medical or veterinary purposes, in particular matrix substance media, and chemical-biological test kits comprising buffer solutions, reagents, media and matrix substance media, all for detecting sepsis for research use, that separate and process microbial and non-microbial cells, including bacteria, yeasts, fungi, particles including virions, and parts of these cells and particles, from a liquid culture

Reagents and media for medical and veterinary diagnostic purposes, in particular culture media, extraction media and diagnostic media; Reagents and media for medical and veterinary diagnostic purposes, in particular culture media, extraction media and diagnostic media, for use with detecting sepsis; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood or blood culture samples for use in detecting sepsis, for medical, clinical and veterinary diagnostics; Reagents and media for medical and veterinary diagnostic purposes, in particular culture media, extraction media and diagnostics media, for use with detecting sepsis, and diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood or blood culture samples for use in detecting sepsis, that separate and process microbial and non-microbial cells, including bacteria, yeasts, fungi, particles including virions, and part of these cells and particles, from a liquid culture, including a body fluid culture, in particular a blood culture

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 23, 2025 GNFN
FINAL REFUSAL E-MAILED
Dec 23, 2025 GNFR
FINAL REFUSAL WRITTEN
Dec 23, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 16, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 28, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 28, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 5, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 4, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 8, 2025 REPR